文献速递瓣膜外科先天性心脏病外科

二尖瓣部分心脏移植:一种有价值的选择?

Mitral Valve Transplantation: a valuable option?
PubMed 文献 · J Thorac Cardiovasc Surg · 2026-10-04

本文报道一例12岁先天性二尖瓣狭窄患者,既往行室间隔缺损修补及21-mm机械二尖瓣瓣上植入,因人工瓣膜狭窄(平均跨瓣压差18 mm Hg)接受同种异体二尖瓣部分心脏移植(PHT)。术后4个月MRI示重度二尖瓣反流(反流分数53%),因前叶脱垂,家属选择机械瓣置换;再次手术见移植瓣环完全整合、组织有活力,组织病理证实乳头肌坏死伴成纤维细胞浸润,而瓣叶和腱索存活。结论认为二尖瓣PHT可行且瓣膜有活力,但远期效果可能取决于瓣下结构的对称平衡再植入。

要点

  • 二尖瓣PHT在缺乏自体乳头肌的患者中技术上可行,移植瓣膜短期存活。
  • 术后4个月出现重度反流(反流分数53%),需再次机械瓣置换。
  • 瓣下结构对称平衡再植入或是影响远期耐久性的关键。

核心结论

  • 二尖瓣部分心脏移植可行且移植瓣膜显示有活力。
  • 远期耐久性可能取决于瓣下结构的对称和平衡再植入,尤其对缺乏自体乳头肌的患者。

研究设计与样本

  • 单病例报告:12岁患者,既往室间隔缺损修补及21-mm机械二尖瓣瓣上植入,因先天性狭窄导致人工瓣膜狭窄(平均跨瓣压差18 mm Hg)。

主要发现

  • 术前CT用于评估腱索长度,因自体乳头肌缺失。
  • 术后4个月MRI示重度二尖瓣反流,反流分数53%,因前叶脱垂。
  • 再次手术见移植瓣环完全整合、组织有活力;组织病理证实乳头肌坏死伴成纤维细胞浸润,瓣叶和腱索存活。

关键数值与推荐

  • 人工瓣膜狭窄平均跨瓣压差18 mm Hg。
  • 术后4个月MRI反流分数53%。

临床怎么用

  • 二尖瓣PHT可作为缺乏自体乳头肌患者的探索性选择,但需严密监测反流。
  • 瓣下结构再植入时应追求对称平衡,可能减少远期反流风险。

局限性

  • 单病例报告,经验极为有限。
  • 随访仅4个月,远期结果未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Partial heart transplantation (PHT) offers a growth-accommodating alternative to mechanical valve replacement in congenital heart disease. While experience with semilunar valve PHT is expanding, application to atrioventricular valves remains extremely limited. We report the first mitral valve PHT at our institution, focusing on technical considerations and lessons learned. CASE SUMMARY: A 12-year-old patient with prior ventricular septal defect closure and supra-annular implantation of a 21-mm mechanical mitral valve due to congenital stenosis developed prosthetic stenosis (mean gradient 18 mm Hg). Evaluation confirmed suitability for mitral valve PHT using an allogenic donor valve. Preoperative CT imaging guided assessment of chordal length, as native papillary muscles were absent. Following removal of the prosthesis, expanded polytetrafluoroethylene sutures were placed on the left ventricular free wall, matched to donor chordal length and anchored near the papillary bases in anticipation of necrosis. The donor valve, retained with a small muscular rim, was secured to the native annulus and tested for competence. An additional suture was placed on the central papillary subhead. Recovery was uneventful, and the patient was discharged on immunosuppression. At four months, MRI demonstrated severe mitral regurgitation (regurgitant fraction 53%) due to anterior leaflet prolapse. The family elected mechanical replacement. Intraoperatively, the transplanted valve showed complete annular integration and tissue viability. Histopathology confirmed papillary necrosis with fibroblast infiltration, while leaflets and chordae remained viable. CONCLUSIONS: Mitral valve PHT is feasible and demonstrates valve viability. Durable outcomes may depend on symmetric and balanced reimplantation of the subvalvar apparatus, particularly in patients lacking native papillary muscles.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Aydin MI, Hanabergh S, Ohara R, et al. Mitral Valve Transplantation: a valuable option? J Thorac Cardiovasc Surg. 2026. PMID: 42830188. doi:10.1016/j.jtcvs.2026.09.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。